Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Cash & Current Investments (2010 - 2026)

Updated

Lexicon Pharmaceuticals' Cash & Current Investments came in at $190.61 million for Q2 2026, up 37.1% from $139.01 million a year earlier and up 11.7% from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Lexicon Pharmaceuticals' Cash & Current Investments was $96.23 million, down 59.6% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of -8.8% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $237.96 million in FY2024 (+40.0%), $170.03 million in FY2023 (+22.9%), $138.36 million in FY2022 (+59.5%) and $86.74 million in FY2021 (-43.0%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments since Q1 2025.
  • Year-over-year, Cash & Current Investments increased in three of the last eight quarters, with an average decline of 16.5%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2023 (growth of 314.3%), and the weakest in Q4 2025 (a decline of 59.6%).
  • Business Quant data shows LXRX's Cash & Current Investments at $170.66 million (Q1 2026), $96.23 million (Q4 2025) and $115.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Lexicon Pharmaceuticals 813.30 Mn 239.86 Mn 653,000.00 190.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 190.61 Mn
Mar 31, 2026 170.66 Mn
Dec 31, 2025 96.23 Mn
Sep 30, 2025 115.95 Mn
Jun 30, 2025 139.01 Mn
Mar 31, 2025 194.84 Mn
Dec 31, 2024 237.96 Mn
Sep 30, 2024 258.37 Mn
Jun 30, 2024 309.96 Mn
Mar 31, 2024 355.60 Mn
Dec 31, 2023 170.03 Mn
Sep 30, 2023 218.43 Mn
Jun 30, 2023 256.74 Mn
Mar 31, 2023 105.94 Mn
Dec 31, 2022 138.36 Mn
Sep 30, 2022 136.20 Mn
Jun 30, 2022 61.97 Mn
Mar 31, 2022 86.50 Mn
Dec 31, 2021 86.74 Mn
Sep 30, 2021 120.92 Mn
API Access

Lexicon Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LXRX&period=max&api_key=YOUR_API_KEY